Virtu KCG Holdings’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Virtu KCG Holdings’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$241K	Buy	34 +27	+386%	+$235K	0.01%	1950
2017 Q1	$55K	Buy	7 +6	+600%	+$41.5K	﹤0.01%	2824
2016 Q4	$4K	Sell	1 -1	-50%	-$5.11K	﹤0.01%	3330
2016 Q3	$17K	Hold	2	–	–	﹤0.01%	2933
2016 Q2	$19K	Buy	+2	New	+$22.4K	﹤0.01%	2804

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's TMBR Position: Q2 2017 in Review

Virtu KCG Holdings increased its Timber Pharmaceuticals, Inc. (TMBR) stake by 386% in Q2 2017, buying an estimated $235K and bringing the position to 34 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #1950.

Virtu KCG Holdings first reported a position in TMBR in Q2 2016 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold TMBR as of Q2 2017.

Virtu KCG Holdings held 34 shares of Timber Pharmaceuticals, Inc. worth $241K as of Q2 2017.
Virtu KCG Holdings bought 27 Timber Pharmaceuticals, Inc. shares in Q2 2017, an estimated $235K.
Timber Pharmaceuticals, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1950 holding.
Virtu KCG Holdings first reported a position in Timber Pharmaceuticals, Inc. in Q2 2016 and has held it in 5 quarters since.
17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.